6-Chloro-1H-indazole(CAS: 698-25-9)

6-Chloro-1H-indazole (CAS: 698-25-9) is subject to regulatory guidelines under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations, and FDA/EPA requirements. Users must ensure compliance with these guidelines for safety data sheets, hazard communication, and proper labeling. Additionally, it is necessary to follow local and national regulations for handling and disposal.

Alternatives to 6-Chloro-1H-indazole (CAS: 698-25-9) in synthesis include other indazoles, such as 4-chloro-1H-indazole or 2-chloro-1H-indazole. Other substitute reagents like chloroacetic acid or chloroform can be used as precursors. The choice depends on the specific reaction conditions and desired product properties.

The market for 6-Chloro-1H-indazole (CAS: 698-25-9) is driven by its use in pharmaceuticals, particularly as a starting material for drug synthesis. Research trends focus on its application in antitumor and anti-inflammatory drugs. Market trends show steady demand with increasing interest in its biological activities and potential therapeutic uses.

Waste containing 6-Chloro-1H-indazole (CAS: 698-25-9) should be collected in compatible containers and stored separately. It should be disposed of via incineration or professional waste disposal services that comply with regulatory requirements. Ensure proper environmental precautions are taken to prevent soil and water contamination during disposal procedures.